arrow
M

Moritz Bewarder

Saarland University
H指数:15
被引数:956

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms

严重COVID-19中IL-1Ra和PGRN的自身抗体与炎症诱导的高磷酸化抗原异构体相关

2026-05-270
OAAI
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP

Perforin 1 A91V胚系背景对接受R-CHOP治疗的侵袭性B-NHL患者的影响

2025-12-070
OA
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma

一项关于talquetamab在138例复发/难治性多发性骨髓瘤患者中的德国多中心真实世界分析

2025-04-170
OAAI
Severe coxsackie virus B5 encephalitis mimics autoimmune limbic encephalitis in a young woman under long-term B-cell depletion with ocrelizumab: A case report

重症柯萨奇病毒B5脑炎在一名接受奥克瑞利珠单抗长期B细胞耗竭治疗的年轻女性中模拟自身免疫性边缘性脑炎:一篇病例报告

2025-02-270
PRE
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis
2024-12-010
OAAI
CD16+as predictive marker for early relapse in aggressive B-NHL/DLBCL patients
2024-09-280
OAAI
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas

高N糖基化SEL1L3作为原发性玻璃体视网膜淋巴瘤的自身抗原b细胞受体靶标

2024-04-260
OAAI
Real-world analysis of teclistamab in 123 RRMM patients from Germany
LEUKEMIA
IF13.4
2024-01-2021
OAAI
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies
2024-01-172
OAAI
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study
2023-07-016
OAAI
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
2023-07-013
OAAI
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
2023-05-047
OAAI